According to CNBC’s article, Mylan can lower EpiPen price today, Express Scripts says, Express Scripts’ Chief Medical Officer, Dr. Steve Miller told CNBC, “"If she [Mylan CEO Heather Bresch] wants to lower the price [of the EpiPen] she can lower the price today…We'd pass the savings that we take from the marketplace back to our plans." That is fine, as far as it goes, however, if Express Scripts really wants to help reign in pharmaceutical prices, they could give consumers more say in their medications.

As an example, I take valsartan to control my hypertension. Every three months, I receive a new supply from Express Scripts. Express Scripts puts on the label who manufactures it. In my case, the aalsartan comes from Mylan. Given the behavior of the current CEO of Mylan, I would prefer that none of my medications come from Mylan. Drugs.com lists a dozen generic manufacturers of V]valsartan.

Likewise, I take fenofibrate for high cholesterol. Like with the valsartan, Express Scripts has sent me fenofibrate manufactured by Mylan. I can’t find the list of other manufactures of fenofibrate, but I’m guessing there are choices there as well.

If Express Scripts would start shipping me medications not manufactured by Mylan, it would be a great start. If lots of patients started requesting the medication not be provided by Mylan, if at all possible, it would help return Adam Smith’s invisible hand to the pharmaceutical marketplace and prevent predatory pricing from companies like Mylan.